Racial differences in nitric oxide-mediated vasodilator response to mental stress in the forearm circulation

Hypertension

Volumn 31, Issue 6, 1998, Pages 1235-1239

  Cardillo, Carmine ^a   Kilcoyne, Crescence M ^a   Cannon III, Richard O ^a   Panza, Julio A ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Nitric oxide; Race; Stress; Vasodilation

Indexed keywords

N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; SODIUM CHLORIDE;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOREARM BLOOD FLOW; HEMODYNAMICS; HUMAN; HYPERTENSION; MALE; MENTAL STRESS; NEGRO; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; VASODILATATION;

EID: 0031838355     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.6.1235     Document Type: Article

References (39)

1. Burt VL. Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1981-1991. Hypertension. 1995;25:305-313.
2. Cornoni-Huntley J, LaCroix AZ, Havlik RJ. Race and sex differences in the impact of hypertension in the United States. Arch Intern Med. 1989; 149:78-88.
3. National Center for Health Statistics. Vital Statistics of the United States, 1977: Mortality, II. Hyattsville, Md: US Department of Health, Education, and Welfare; 1977.
4. Gillum RF. Pathophysiology of hypertension in blacks and whites. Hypertension. 1979;1:468-475.
5. Falkner B. Differences in blacks and whites with essential hypertension: biochemistry and endocrine. Hypertension. 1990;15:681-686.
6. Kaplan NM. Ethnic aspects of hypertension. Lancet. 1994;344:450-452.
7. Murphy JK, Alpert BS, Moes DM, Somes GW. Race and cardiovascular reactivity: a neglected relationship. Hypertension. 1986;8:1075-1083.
8. Anderson NB, Lane JD, Muranaka M, Williams RB Jr, Houseworth SJ. Racial differences in blood pressure and forearm vascular responses to the cold face stimulus. Psychosom Med. 1988;50:57-63.
9. Anderson NB, Myers HF, Pickering T, Jackson JS. Hypertension in blacks: psychosocial and biological perspectives. J Hypertens. 1989;7: 161-172.
10. McAdoo WG, Weinberger MH, Miller JZ, Finenberg NS, Grim CE. Race and gender influence hemodynamic responses to psychological and physical stimuli. J Hypertens. 1990;8:961-967.
11. Saab PG, Llabre MM, Hurwitz BE, Frame CA, Reineke LJ, Fins AI, McCalla J, Cieply LK, Schneiderman N. Myocardial and peripheral vascular responses to behavioral challenges and their stability in black and white Americans. Psychophysiology. 1992;29:384-397.
12. Light KC, Turner JR, Hinderliter AL, Sherwood A. Race and gender comparisons, I: hemodynamic responses to a series of stressors. Health Psychol. 1993;12:354-365.
13. Dietz NM, Rivera JM, Eggener SE, Fix RT, Warner DO, Joyner MJ. Nitric oxide contributes to the rise in forearm blood flow during mental stress in humans. J Physiol (Lond). 1994;480:361-368.
14. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO III, Panza JA. Role of nitric oxide in the vasodilator response to mental stress. Am J Cardiol. 1997;80:1070-1074.
15. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
16. Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Circulation. 1990;81:1762-1767.
17. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. Circulation. 1993;87: 1468-1474.
18. Hirooka Y, Imaizumi T, Masaki H, Ando S, Harada S, Momohara M, Takeshida A. Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients. Hypertension. 1992;20:175-180.
19. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens. 1992;10:1025-1031.
20. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 1993;21:929-933.
21. Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I, Salvetti A. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation. 1996;94:1298-1303.
22. Whitney RJ. Measurement of changes in human limb volume by means of a mercury-in-rubber strain gauge. J Physiol (Lond). 1948;109:5P-6P.
23. Kerslake DM. The effect of application of an arterial occlusion cuff to the wrist on the blood flow in the human forearm. J Physiol (Lond). 1949; 108:451-457.
24. Bohme E, Graf H, Schultz G. Effects of sodium nitroprusside and other smooth muscle relaxant on cyclic-GMP formation in smooth muscle and platelets. Adv Cycl Nucl Res. 1978;9:131-143.
25. Rees DD, Palmer RM, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol. 1989;96:418-424.
26. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Physiol Rev. 1991;43:109-142.
27. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO III, Panza JA. Abnormal nitric oxide-dependent forearm vasodilation to mental stress in patients with essential hypertension. Circulation. 1996;94:I-459. Abstract.
28. Rembold CM. Regulation of contraction and relaxation in arterial smooth muscle. Hypertension. 1992;20:129-137.
29. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature. 1994;372:231-236.
30. Sudhir K, Forman A, Yi S-L, Sorof J, Schmidlin O, Sebastian A, Morris RC Jr. Reduced dietary potassium reversibly enhances vasopressor response to stress in African Americans. Hypertension. 1997;29: 1083-1090.
31. Carlsson I, Sollevi A, Wennmalm A. The role of myogenic relaxation, adenosine and prostaglandins in human reactive hyperemia. J Physiol (Lond). 1987;389:147-161.
32. Tagawa T, Imaizumi T, Endo T, Shiramoto M, Harasawa Y, Takeshita A. Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation. 1994;90:2285-2290.
33. Bassett DR Jr, Duey WJ, Walker AJ, Howley ET, Bond V. Racial differences in maximal vasodilator capacity of forearm resistance vessels in normotensive young adults. Am J Hypertens. 1992;5:781-786.
34. Hinderliter AL, Sager AR, Sherwood A, Light KC, Girdler SS, Willis PW IV. Ethnic differences in forearm vasodilator capacity. Am J Cardiol. 1996;78:208-211.
35. Folkow B, Grimby G, Thulesius O. Adaptive structural changes in the vascular walls in hypertension and their relation to control of peripheral resistance. Acta Physiol Scand. 1958;44:255-272.
36. Takeshita A, Imaizumi T, Ashihara T, Yamamoto K, Hoka S, Nakamura M. Limited maximal vasodilator capacity of forearm resistance vessels in normotensive young men with a family predisposition to hypertension. Circ Res. 1982;50:671-677.
37. Brod J, Fencl V, Hejlz, Jirka J. Circulatory changes underlying blood pressure elevation during acute emotional stress (mental arithmetic) in normotensive and hypertensive subjects. Clin Sci. 1959;18:269-279.
38. Saab PG, Llabre MM, Hurwitz BE, Frame CA, Reineke LJ, Fins AI, McCalla J, Cieply LK, Schneiderman N. Myocardial and peripheral vascular responses to behavioral challenges and their stability in black and white Americans. Psychophysiology. 1992;29:384-397.
39. Light KC, Turner JR, Hinderliter AL, Sherwood A. Race and gender comparisons, I: hemodynamic responses to a series of stressors. Health Psychol. 1993;12:354-365.